Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo
(Q73339600)
scientific article published on 01 September 1999
scientific article published on 01 September 1999
Language: